The peptide is synthesized using recombinant DNA technology:
Expression Systems: Primarily produced in E. coli or yeast, with a His-tag for affinity chromatography .
Formulation: Supplied in Tris-HCl buffer (pH 8.0) with glycerol and urea to enhance solubility .
Gut Motility: Induces contractions in insect midgut tissues, akin to vertebrate tachykinins .
Receptor Interaction: Binds to G protein-coupled receptors (GPCRs) such as BNGR-A24 in Bombyx mori, triggering intracellular signaling via cAMP or cGMP pathways .
Stress Response: Modulates ion and water transport in Malpighian tubules under desiccation or osmotic stress .
Structural Divergence: Unlike vertebrate tachykinins (C-terminal motif: –Phe-X-Gly-Leu-Met-NH₂), Scg-midgut-TK retains the arthropod-specific –Phe-X-Gly-Y-Arg-NH₂ motif .
Precursor Diversity: Encoded by a precursor polypeptide distinct from vertebrate preprotachykinins, highlighting evolutionary divergence .
Physiological Studies: Used to investigate TKRP signaling in insect models (e.g., Drosophila, Bombyx mori) .
Receptor Profiling: Identifies ligand specificity of GPCRs like TkR99D and PK2-R1 in in vitro assays .
Drug Development: Serves as a template for designing analogs targeting invertebrate-specific TKRP receptors, with applications in pest control .
Functional Redundancy: Overlap with ion transport peptide (ITP) signaling complicates in vivo studies .
Structural Stability: Requires urea or glycerol for solubility, limiting in vivo applications .
Unresolved Pathways: Mechanisms linking Scg-midgut-TK to metabolic regulation remain poorly understood .
How do Scg-TK1 receptors compare across insect species in ligand selectivity?
What conflicting data exist regarding Scg-TK1’s role in phase polyphenism?
Transcriptomic data: Phase-specific expression of Scg-TK1 precursors is observed in gregarious locusts , but functional assays show no direct behavioral modulation .
Resolution: Pair RNAi knockdown with behavioral assays (e.g., locomotion tracking) and parallel measurement of gut motility to disentangle neuromodulatory vs. peripheral roles .
Can Scg-TK1 cross-activate vertebrate tachykinin receptors, and what are the implications?
Scg-TK1 exhibits weak activity (<10% potency of substance P) on mammalian NK₁ receptors in vitro . To test cross-reactivity:
How to resolve low yields in recombinant Scg-TK1 production?
What controls are critical when analyzing Scg-TK1’s ion transport functions?